Dr. Kathie Sollweck discusses the impact of sequencing and PCR on oncology research.
Dr. Kathie Sollweck, Senior Medical Affairs Manager for Oncology at Thermo Fisher Scientific, joins the Absolute Gene-ius team to explore how liquid biopsy, sequencing, and PCR are transforming precision oncology research. The conversation spans unmet needs in cancer research, MRD monitoring, and a candid look at career paths beyond academia.
Explore listener stats, chart rankings, contacts and more on the Absolute Gene-ius podcast page.